FDA. As used herein, “FDA” means the United States Food and Drug Administration, or any successor agency.
Appears in 4 contracts
Sources: Supply and Manufacturing Agreement, Supply and Manufacturing Agreement (Quanterix Corp), Supply and Manufacturing Agreement (Quanterix Corp)
FDA. As used herein, “FDA” means shall mean the United States Food and Drug Administration, or any a successor agencyagency thereto.
Appears in 3 contracts
Sources: License Agreement (Discovery Partners International Inc), License Agreement (Infinity Pharmaceuticals, Inc.), License Agreement (Discovery Partners International Inc)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, Administration or any successor agencyentity thereto, and any similar Governmental Authority outside of the United States.
Appears in 3 contracts
Sources: Technology License and Services Agreement (Synaptogenix, Inc.), Technology License and Services Agreement (Neurotrope, Inc.), Technology License and Services Agreement (Neurotrope, Inc.)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, Administration of the United States Department of Health and Human Services or any successor agencyagency thereto.
Appears in 2 contracts
Sources: Master Services Agreement (Semnur Pharmaceuticals, Inc.), Master Services Agreement (Vickers Vantage Corp. I)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, or and any successor agencyagency of the United States government.
Appears in 2 contracts
Sources: Three Way Agreement, Three Way Agreement (Nabriva Therapeutics PLC)
FDA. As used herein, The term “FDA” means shall mean the Food and Drug Administration of the United States Food of America and Drug Administration, or any successor agencyagency(ies) or authority having substantially the same function.
Appears in 2 contracts
Sources: Exclusive Research, Development Option and License Agreement (Magenta Therapeutics, Inc.), Exclusive Research, Development Option and License Agreement (Magenta Therapeutics, Inc.)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto, having the administrative authority to regulate the marketing of human pharmaceutical products or biological therapeutic products, delivery systems and devices in the United States of America.
Appears in 2 contracts
Sources: Research Funding and Option Agreement (aTYR PHARMA INC), Research Funding and Option Agreement (aTYR PHARMA INC)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, Administration or any successor agency.
Appears in 2 contracts
Sources: Merger Agreement (RayzeBio, Inc.), Agreement and Plan of Merger (Turning Point Therapeutics, Inc.)
FDA. As used herein, “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
FDA. As used herein, “FDA” FDA means the United States Food and Drug Administration, or any successor agencyagency with similar responsibilities.
Appears in 1 contract
FDA. As used herein, “FDA” means the United States Food and Drug AdministrationAdministration of the United States Department of Health and Human Services, or any successor agencyagency thereto.
Appears in 1 contract
Sources: Commercial Manufacturing Services Agreement (Heron Therapeutics, Inc. /De/)
FDA. As used herein, “FDA” means shall mean the United States Food and Drug Administration, or Administration and any successor agencyagency or authority thereto.
Appears in 1 contract
Sources: Intellectual Property License Agreement (Hepion Pharmaceuticals, Inc.)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
FDA. As used herein, “FDA” means shall mean the United States U.S. Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
Sources: Stock Purchase Agreement (Aclaris Therapeutics, Inc.)
FDA. As used herein, “The term "FDA” means " shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
Sources: License and Sub License Agreement (Bioenvision Inc)